SELLAS Life Sciences Group, Inc

Q2 2026 13F Holders

Symbol
SLS
CUSIP
81642T209
Type
Equity
Class
COM NEW
Num filings
233
Total reported value, excl. options
$1.22 B
Manager Report Date Value ($000) Shares Option Type